Abstract:Marshall JK, Thabane M, Garg AX, et al; Walkerton Health Study Investigators. Eight year prognosis of postinfectious irritable bowel syndrome following waterborne bacterial dysentery. Gut 2010;59:605–611.Postinfectious irritable bowel syndrome (PI-IBS), defined as the acute onset of symptoms meeting diagnostic criteria for IBS with ≥2 of the following signs or symptoms: fever, vomiting, diarrhea, or positive stool culture (Gastroenterology 2003;124:1662–1671), is a well-recognized but poorly understood complication of acute gastroenteritis because its natural history and outcomes remain largely unknown. Existing studies are limited by either a small study population or a short interval of follow-up. To this end, the Walkerton Health Study (WHS) Investigators have published an 8-year follow-up of 1166 patients since a tragic contamination of the water supply with Escherichia coli 0:157:H7, Campylobacter jejuni, and other pathogens in 2000 (Gastroenterology 2006;131:445–450). This study was initiated 2 years after the outbreak.Patients were eligible for the study cohort if they were adults (age ≥16 years), lived in Walkerton at the time of the outbreak, and had no history of IBS, celiac disease, or inflammatory bowel disease based on self-report and a review of available medical records. Only subjects who enrolled within 2 years of the formation of the WHS were included to minimize recall bias. Patients in the PI-IBS cohort were divided into 3 exposure groups: (1) those who reported no acute illness during the outbreak (controls); (2) those who self-reported gastroenteritis unsubstantiated by a review of available health records; and (3) those who reported acute illness substantiated by review of records, by a local health survey, or by a positive stool culture. IBS with diarrhea (IBS-D) was diagnosed in those reporting >3 bowel movements per day and watery stools or urgency ≥25% of the time. IBS with constipation (IBS-C) was defined in those reporting <3 bowel movements per week and hard/lumpy stools or straining to evacuate ≥25% of the time. Those who did not meet criteria for either IBS-D or IBS-C were diagnosed with unclassified IBS (IBS-U). In addition, the authors also used the Rome III subclassification based on stool form to determine bowel habit subtype (Gastroenterology 2006;130:1480–1491). Risk factors for PI-IBS, including age, gender, exposure status, illness features during the outbreak, self-reported history of anxiety or depression, antibiotic use, and direct contact with livestock, were tested at 4, 6, and 8 years after exposure using univariable and multivariable logistic regression analysis to adjust for confounding factors.By 2003, a total of 4315 individuals were enrolled in the WHS, and ultimately 2246 (52.1%) were excluded by the above criteria. Returning participants in 2008 were older and more likely to be female compared with terminates; however, no differences between exposure to gastroenteritis existed between participants and terminates. By 2008, of the 2069 initially enrolled in the PI-IBS study cohort, only 1166 eligible patients remained—742 subjects exposed to acute gastroenteritis (either self-reported or clinically suspected gastroenteritis) and 424 unexposed controls.The overall prevalence of IBS among the 742 subjects exposed to acute gastroenteritis decreased from 28.3% at 2–3 years to 21.4% at 4 years and to 14.3% at 6 years. At 8 years, the prevalence of IBS was significantly different between cases and controls (15.4% vs 5.4%; P < .0001). In a subanalysis of the 210 patients with PI-IBS in 2002/2003, Rome I criteria for IBS were still fulfilled in 50.0% at 4 years, in 34.4% at 6 years, and in 34.8% at 8 years. A numerically lower but similar proportion of subjects without acute gastroenteritis but with “sporadic” IBS defined by Rome I criteria in 2002 or 2003 continued to meet criteria for IBS over the same period of time (10/45 subjects [22.2%]). In 2008, 1.8% of cases with a history of acute gastroenteritis were diagnosed with IBS for the first time compared with 1.9% of controls (P = .869). Additional post hoc analysis was performed assuming conservatively that all patients who failed to return were healthy and did not have IBS. The prevalence of IBS decreased from 30.4% in 2002/2003 to 8.3% in 2008 among cases exposed to acute gastroenteritis and from 10.1% to 3.3% in controls over that same period.Risk factors for PI-IBS were evaluated at each time period by multivariable logistic regression. Consistent predictors of PI-IBS included female gender and weight loss for all time points, young age at all points except 2004, prolonged diarrhea at all time points except 2008, and abdominal pain during the acute illness in 2002/2003 and in 2004. Other variables predictive of PI-IBS at a single time point include preexisting psychological disorders (2008), peak stool frequency (2006), fever (2008), and blood per rectum during the acute enteric illness (2002/2003).Of the 2069 enrolled in 2002/2003 eligible for the PI-IBS study cohort, 488 total patients (cases and controls) met Rome I criteria for IBS at enrollment (23.6%). Of these, 41.8% were subclassified as IBS-D, 10.7% as IBS-C, and 47.5% as IBS-U. When bowel habit was subclassified by Rome III criteria in these patients, 42.4% had IBS-D, 20.1% had IBS-C, 15.4% had mixed IBS, and 22.3% had IBS-U. Over the subsequent 6-year follow-up period, a significant number of IBS-D patients were reclassified by their original bowel habit criteria as IBS-C, IBS-U, and non-IBS; similar phenotypic instability was seen in those initially classified as IBS-C and IBS-U.The authors point out several weaknesses of the study. First, only a minority (exact number not revealed) of patients had culture-proven infection. Second, of the original 4315 WHS enrollees, only 53.5% returned for reassessment in 2008, although no differences in exposure to gastroenteritis was reported between returnees and terminates. Third, misclassification of PI-IBS could not be completely excluded because the authors were unable to assess the presence of gastrointestinal symptoms and psychological profile before the outbreak.CommentThe current WHS is the largest study published to date following patients exposed and unexposed to acute gastroenteritis for >2 years. The size and duration of this study clearly add significant value to our understanding of PI-IBS. Furthermore, the authors have shown more definitively that the severity of the initial acute bacterial gastroenteritis (including abdominal cramps, fever, weight loss, blood in stool, and duration of diarrhea >7 days) all predict presence of PI-IBS at various time points between 2 and 8 years after infection. Previously, a long duration of diarrhea had been shown in some studies to predict PI-IBS (BMJ 1997;314:779–782; Am J Gastroenterol 2009;104:2267–2274), but not in others (Aliment Pharmacol Ther 2007;26:535–544). The follow-up WHS analysis confirmed findings from prior studies demonstrating that young age, female gender, and a history of prior anxiety or depression increase risk for PI-IBS (Clin Gastroenterol Hepatol 2007;5:465–469; Gut 2007;56:1066–1071). The authors have also shown that the prevalence of PI-IBS at 6 and 8 years are similar (14.3% vs 15.4%), whereas previously it was reported that 57% of patients in a small cohort of 14 patients had PI-IBS at 6 years (Gut 2002;51:410–413).In this study, the overall prevalence of IBS in the returning 742 cohort participants at 8 years was significantly greater in the cases exposed to acute bacterial gastroenteritis in 2000 as compared with controls representing sporadic cases (15.4% vs 5.4%; P < .0001). In the 210 participants who were diagnosed with IBS in 2002/2003 (either sporadic or PI-IBS), persistence of illness was seen in both groups, although the percentage was greater in the PI-IBS group (34.8% vs 22.2% at the 8-year follow-up). These values differ markedly from those reported by El-Serag et al in a systematic review based on 5 studies that reported that only 12%–38% of symptom-free patients experienced complete resolution of symptoms at a median follow-up duration of 2 years (Aliment Pharmacol Ther 2004;19:861–870). In a 6th study, 29% of patients were found to have IBS-related visits during a median follow-up of 12 years, a number more consistent with these findings (Ann Intern Med 1995;122:107–112.) Reasons that may account for differences in prevalence of IBS persistence between the WHS study and the studies included in El Serag et al's systematic review is that the latter included both retrospective and prospective studies, diagnostic criteria varied, and the prevalence of women ranged from 36% to 100%. An additional finding in the WHS was that there was no greater likelihood of developing de novo IBS at 8 years in cases exposed to acute bacterial gastroenteritis versus controls.Some limitations of the study are worth mentioning. First, even though the authors excluded enrollees beyond 2002/2003, recall bias of symptoms even at 2 years can cause misclassification of both cases and controls. Patients exposed to a severe cause of acute gastroenteritis, for instance, may be less apt to remember any prior milder IBS symptoms before the outbreak. Furthermore, Parry et al demonstrated that IBS is more frequently seen before diagnosis in patients with acute bacterial gastroenteritis (Am J Gastroenterol 2003;98:327–331), making exclusion of IBS especially important. The WHS also did not report in this study about other functional somatic syndromes such as fibromyalgia, chronic fatigue syndrome, and interstitial cystitis, which frequently coexist with IBS. It is conceivable that participants did not have preinfection IBS but had another functional syndrome that could have predisposed them to developing IBS. Second, in evaluating differences between participants and terminates in Table 2, the authors characterized all patients from the WHS cohort including those excluded by the study criteria. The addition of these patients to this table make it difficult to truly assess for differences between participants included in the study and terminates from the study, a potential concern if it is believed that those with more severe illness are disproportionately more likely to seek health care (thereby increasing the prevalence of PI-IBS). The terminates in 2008 had some features that are associated with greater risk for PI-IBS (fever, weight loss, more with a longer duration of diarrhea) but other features that are not (fewer women, lower stool frequency). Third, it is unclear if there was a misdiagnosis of PI-IBS or if these patients had developed other diseases at the time of follow-up because health records were not reviewed throughout the duration of the study. For instance, a small increased risk of inflammatory bowel disease has been reported after acute infectious gastroenteritis (1.2% in cases vs 0.5% in controls; Gastroenterology 2009;137:415–418). Fourth, no assessment of the severity of PI-IBS at various time points was performed. It would have been interesting to determine whether certain clinical factors predict a more severe disease course in PI-IBS. Recent studies have identified clinical features that predict IBS severity in a non–PI-IBS population (Am J Gastroenterol 2008;103:2536–2543) and that specific features of pain drive IBS illness severity more than other features including intensity, constancy, frequency, and predictability of pain (Aliment Pharmacol Ther 2010;32:1192–1202). Lastly, patients were diagnosed by Rome I criteria as opposed to Rome II criteria, which are more restrictive and have been shown to produce lower estimates of prevalence (Am J Gastroenterol 2000;95:3176–183). In a meta-analysis, the incidence of PI-IBS ranged from 3% to 14% in studies that used Rome II criteria versus 16% to 32% in studies that used Rome I criteria (Aliment Pharmacol Ther 2007;26:535–544).Recently, the WHS investigators have also identified several genes that encode proteins involved in epithelial cell barrier function and the innate immune response to enteric bacteria that are associated with development of PI-IBS (Gastroenterology 2010;138:1502–1513). This finding suggests that certain individuals may be more predisposed to developing PI-IBS when exposed to a gastroenteritis. However, alterations in gene expression need to be confirmed with microarray analysis because gene expression can be altered by environmental influences (eg, chronic stress which is a predictor of PI-IBS (Gut 1999;44:400-6). Future studies should evaluate whether Toll-like receptor-9, interleukin-6, and CDH1 genetic variants are also associated with non–PI-IBS.The WHS cohort continues to provide invaluable data regarding the long-term prognosis of PI-IBS. As these patients are followed over the course of their lives, it will be interesting to see how and if their symptoms continue to evolve. Will they be more likely to develop inflammatory bowel disease or other gastrointestinal or nongastrointestinal illnesses? Will they continue to demonstrate subtype phenotypic instability? Will their symptoms be comparable in severity with those with de novo IBS? Finally, do PI-IBS patients respond to different therapies (eg, anti-inflammatory agents) compared with non–PI-IBS patients? The WHS Investigators have followed a truly unique cohort of patients unmatched in their size, their duration of follow-up, and their availability of DNA samples. From a national tragedy affecting thousands and resulting in 6 deaths, the WHS Investigators have published a detailed, 8-year follow-up of survivors of this cohort, contributing immensely to our knowledge of the natural history of PI-IBS. Marshall JK, Thabane M, Garg AX, et al; Walkerton Health Study Investigators. Eight year prognosis of postinfectious irritable bowel syndrome following waterborne bacterial dysentery. Gut 2010;59:605–611. Postinfectious irritable bowel syndrome (PI-IBS), defined as the acute onset of symptoms meeting diagnostic criteria for IBS with ≥2 of the following signs or symptoms: fever, vomiting, diarrhea, or positive stool culture (Gastroenterology 2003;124:1662–1671), is a well-recognized but poorly understood complication of acute gastroenteritis because its natural history and outcomes remain largely unknown. Existing studies are limited by either a small study population or a short interval of follow-up. To this end, the Walkerton Health Study (WHS) Investigators have published an 8-year follow-up of 1166 patients since a tragic contamination of the water supply with Escherichia coli 0:157:H7, Campylobacter jejuni, and other pathogens in 2000 (Gastroenterology 2006;131:445–450). This study was initiated 2 years after the outbreak. Patients were eligible for the study cohort if they were adults (age ≥16 years), lived in Walkerton at the time of the outbreak, and had no history of IBS, celiac disease, or inflammatory bowel disease based on self-report and a review of available medical records. Only subjects who enrolled within 2 years of the formation of the WHS were included to minimize recall bias. Patients in the PI-IBS cohort were divided into 3 exposure groups: (1) those who reported no acute illness during the outbreak (controls); (2) those who self-reported gastroenteritis unsubstantiated by a review of available health records; and (3) those who reported acute illness substantiated by review of records, by a local health survey, or by a positive stool culture. IBS with diarrhea (IBS-D) was diagnosed in those reporting >3 bowel movements per day and watery stools or urgency ≥25% of the time. IBS with constipation (IBS-C) was defined in those reporting <3 bowel movements per week and hard/lumpy stools or straining to evacuate ≥25% of the time. Those who did not meet criteria for either IBS-D or IBS-C were diagnosed with unclassified IBS (IBS-U). In addition, the authors also used the Rome III subclassification based on stool form to determine bowel habit subtype (Gastroenterology 2006;130:1480–1491). Risk factors for PI-IBS, including age, gender, exposure status, illness features during the outbreak, self-reported history of anxiety or depression, antibiotic use, and direct contact with livestock, were tested at 4, 6, and 8 years after exposure using univariable and multivariable logistic regression analysis to adjust for confounding factors. By 2003, a total of 4315 individuals were enrolled in the WHS, and ultimately 2246 (52.1%) were excluded by the above criteria. Returning participants in 2008 were older and more likely to be female compared with terminates; however, no differences between exposure to gastroenteritis existed between participants and terminates. By 2008, of the 2069 initially enrolled in the PI-IBS study cohort, only 1166 eligible patients remained—742 subjects exposed to acute gastroenteritis (either self-reported or clinically suspected gastroenteritis) and 424 unexposed controls. The overall prevalence of IBS among the 742 subjects exposed to acute gastroenteritis decreased from 28.3% at 2–3 years to 21.4% at 4 years and to 14.3% at 6 years. At 8 years, the prevalence of IBS was significantly different between cases and controls (15.4% vs 5.4%; P < .0001). In a subanalysis of the 210 patients with PI-IBS in 2002/2003, Rome I criteria for IBS were still fulfilled in 50.0% at 4 years, in 34.4% at 6 years, and in 34.8% at 8 years. A numerically lower but similar proportion of subjects without acute gastroenteritis but with “sporadic” IBS defined by Rome I criteria in 2002 or 2003 continued to meet criteria for IBS over the same period of time (10/45 subjects [22.2%]). In 2008, 1.8% of cases with a history of acute gastroenteritis were diagnosed with IBS for the first time compared with 1.9% of controls (P = .869). Additional post hoc analysis was performed assuming conservatively that all patients who failed to return were healthy and did not have IBS. The prevalence of IBS decreased from 30.4% in 2002/2003 to 8.3% in 2008 among cases exposed to acute gastroenteritis and from 10.1% to 3.3% in controls over that same period. Risk factors for PI-IBS were evaluated at each time period by multivariable logistic regression. Consistent predictors of PI-IBS included female gender and weight loss for all time points, young age at all points except 2004, prolonged diarrhea at all time points except 2008, and abdominal pain during the acute illness in 2002/2003 and in 2004. Other variables predictive of PI-IBS at a single time point include preexisting psychological disorders (2008), peak stool frequency (2006), fever (2008), and blood per rectum during the acute enteric illness (2002/2003). Of the 2069 enrolled in 2002/2003 eligible for the PI-IBS study cohort, 488 total patients (cases and controls) met Rome I criteria for IBS at enrollment (23.6%). Of these, 41.8% were subclassified as IBS-D, 10.7% as IBS-C, and 47.5% as IBS-U. When bowel habit was subclassified by Rome III criteria in these patients, 42.4% had IBS-D, 20.1% had IBS-C, 15.4% had mixed IBS, and 22.3% had IBS-U. Over the subsequent 6-year follow-up period, a significant number of IBS-D patients were reclassified by their original bowel habit criteria as IBS-C, IBS-U, and non-IBS; similar phenotypic instability was seen in those initially classified as IBS-C and IBS-U. The authors point out several weaknesses of the study. First, only a minority (exact number not revealed) of patients had culture-proven infection. Second, of the original 4315 WHS enrollees, only 53.5% returned for reassessment in 2008, although no differences in exposure to gastroenteritis was reported between returnees and terminates. Third, misclassification of PI-IBS could not be completely excluded because the authors were unable to assess the presence of gastrointestinal symptoms and psychological profile before the outbreak. CommentThe current WHS is the largest study published to date following patients exposed and unexposed to acute gastroenteritis for >2 years. The size and duration of this study clearly add significant value to our understanding of PI-IBS. Furthermore, the authors have shown more definitively that the severity of the initial acute bacterial gastroenteritis (including abdominal cramps, fever, weight loss, blood in stool, and duration of diarrhea >7 days) all predict presence of PI-IBS at various time points between 2 and 8 years after infection. Previously, a long duration of diarrhea had been shown in some studies to predict PI-IBS (BMJ 1997;314:779–782; Am J Gastroenterol 2009;104:2267–2274), but not in others (Aliment Pharmacol Ther 2007;26:535–544). The follow-up WHS analysis confirmed findings from prior studies demonstrating that young age, female gender, and a history of prior anxiety or depression increase risk for PI-IBS (Clin Gastroenterol Hepatol 2007;5:465–469; Gut 2007;56:1066–1071). The authors have also shown that the prevalence of PI-IBS at 6 and 8 years are similar (14.3% vs 15.4%), whereas previously it was reported that 57% of patients in a small cohort of 14 patients had PI-IBS at 6 years (Gut 2002;51:410–413).In this study, the overall prevalence of IBS in the returning 742 cohort participants at 8 years was significantly greater in the cases exposed to acute bacterial gastroenteritis in 2000 as compared with controls representing sporadic cases (15.4% vs 5.4%; P < .0001). In the 210 participants who were diagnosed with IBS in 2002/2003 (either sporadic or PI-IBS), persistence of illness was seen in both groups, although the percentage was greater in the PI-IBS group (34.8% vs 22.2% at the 8-year follow-up). These values differ markedly from those reported by El-Serag et al in a systematic review based on 5 studies that reported that only 12%–38% of symptom-free patients experienced complete resolution of symptoms at a median follow-up duration of 2 years (Aliment Pharmacol Ther 2004;19:861–870). In a 6th study, 29% of patients were found to have IBS-related visits during a median follow-up of 12 years, a number more consistent with these findings (Ann Intern Med 1995;122:107–112.) Reasons that may account for differences in prevalence of IBS persistence between the WHS study and the studies included in El Serag et al's systematic review is that the latter included both retrospective and prospective studies, diagnostic criteria varied, and the prevalence of women ranged from 36% to 100%. An additional finding in the WHS was that there was no greater likelihood of developing de novo IBS at 8 years in cases exposed to acute bacterial gastroenteritis versus controls.Some limitations of the study are worth mentioning. First, even though the authors excluded enrollees beyond 2002/2003, recall bias of symptoms even at 2 years can cause misclassification of both cases and controls. Patients exposed to a severe cause of acute gastroenteritis, for instance, may be less apt to remember any prior milder IBS symptoms before the outbreak. Furthermore, Parry et al demonstrated that IBS is more frequently seen before diagnosis in patients with acute bacterial gastroenteritis (Am J Gastroenterol 2003;98:327–331), making exclusion of IBS especially important. The WHS also did not report in this study about other functional somatic syndromes such as fibromyalgia, chronic fatigue syndrome, and interstitial cystitis, which frequently coexist with IBS. It is conceivable that participants did not have preinfection IBS but had another functional syndrome that could have predisposed them to developing IBS. Second, in evaluating differences between participants and terminates in Table 2, the authors characterized all patients from the WHS cohort including those excluded by the study criteria. The addition of these patients to this table make it difficult to truly assess for differences between participants included in the study and terminates from the study, a potential concern if it is believed that those with more severe illness are disproportionately more likely to seek health care (thereby increasing the prevalence of PI-IBS). The terminates in 2008 had some features that are associated with greater risk for PI-IBS (fever, weight loss, more with a longer duration of diarrhea) but other features that are not (fewer women, lower stool frequency). Third, it is unclear if there was a misdiagnosis of PI-IBS or if these patients had developed other diseases at the time of follow-up because health records were not reviewed throughout the duration of the study. For instance, a small increased risk of inflammatory bowel disease has been reported after acute infectious gastroenteritis (1.2% in cases vs 0.5% in controls; Gastroenterology 2009;137:415–418). Fourth, no assessment of the severity of PI-IBS at various time points was performed. It would have been interesting to determine whether certain clinical factors predict a more severe disease course in PI-IBS. Recent studies have identified clinical features that predict IBS severity in a non–PI-IBS population (Am J Gastroenterol 2008;103:2536–2543) and that specific features of pain drive IBS illness severity more than other features including intensity, constancy, frequency, and predictability of pain (Aliment Pharmacol Ther 2010;32:1192–1202). Lastly, patients were diagnosed by Rome I criteria as opposed to Rome II criteria, which are more restrictive and have been shown to produce lower estimates of prevalence (Am J Gastroenterol 2000;95:3176–183). In a meta-analysis, the incidence of PI-IBS ranged from 3% to 14% in studies that used Rome II criteria versus 16% to 32% in studies that used Rome I criteria (Aliment Pharmacol Ther 2007;26:535–544).Recently, the WHS investigators have also identified several genes that encode proteins involved in epithelial cell barrier function and the innate immune response to enteric bacteria that are associated with development of PI-IBS (Gastroenterology 2010;138:1502–1513). This finding suggests that certain individuals may be more predisposed to developing PI-IBS when exposed to a gastroenteritis. However, alterations in gene expression need to be confirmed with microarray analysis because gene expression can be altered by environmental influences (eg, chronic stress which is a predictor of PI-IBS (Gut 1999;44:400-6). Future studies should evaluate whether Toll-like receptor-9, interleukin-6, and CDH1 genetic variants are also associated with non–PI-IBS.The WHS cohort continues to provide invaluable data regarding the long-term prognosis of PI-IBS. As these patients are followed over the course of their lives, it will be interesting to see how and if their symptoms continue to evolve. Will they be more likely to develop inflammatory bowel disease or other gastrointestinal or nongastrointestinal illnesses? Will they continue to demonstrate subtype phenotypic instability? Will their symptoms be comparable in severity with those with de novo IBS? Finally, do PI-IBS patients respond to different therapies (eg, anti-inflammatory agents) compared with non–PI-IBS patients? The WHS Investigators have followed a truly unique cohort of patients unmatched in their size, their duration of follow-up, and their availability of DNA samples. From a national tragedy affecting thousands and resulting in 6 deaths, the WHS Investigators have published a detailed, 8-year follow-up of survivors of this cohort, contributing immensely to our knowledge of the natural history of PI-IBS. The current WHS is the largest study published to date following patients exposed and unexposed to acute gastroenteritis for >2 years. The size and duration of this study clearly add significant value to our understanding of PI-IBS. Furthermore, the authors have shown more definitively that the severity of the initial acute bacterial gastroenteritis (including abdominal cramps, fever, weight loss, blood in stool, and duration of diarrhea >7 days) all predict presence of PI-IBS at various time points between 2 and 8 years after infection. Previously, a long duration of diarrhea had been shown in some studies to predict PI-IBS (BMJ 1997;314:779–782; Am J Gastroenterol 2009;104:2267–2274), but not in others (Aliment Pharmacol Ther 2007;26:535–544). The follow-up WHS analysis confirmed findings from prior studies demonstrating that young age, female gender, and a history of prior anxiety or depression increase risk for PI-IBS (Clin Gastroenterol Hepatol 2007;5:465–469; Gut 2007;56:1066–1071). The authors have also shown that the prevalence of PI-IBS at 6 and 8 years are similar (14.3% vs 15.4%), whereas previously it was reported that 57% of patients in a small cohort of 14 patients had PI-IBS at 6 years (Gut 2002;51:410–413). In this study, the overall prevalence of IBS in the returning 742 cohort participants at 8 years was significantly greater in the cases exposed to acute bacterial gastroenteritis in 2000 as compared with controls representing sporadic cases (15.4% vs 5.4%; P < .0001). In the 210 participants who were diagnosed with IBS in 2002/2003 (either sporadic or PI-IBS), persistence of illness was seen in both groups, although the percentage was greater in the PI-IBS group (34.8% vs 22.2% at the 8-year follow-up). These values differ markedly from those reported by El-Serag et al in a systematic review based on 5 studies that reported that only 12%–38% of symptom-free patients experienced complete resolution of symptoms at a median follow-up duration of 2 years (Aliment Pharmacol Ther 2004;19:861–870). In a 6th study, 29% of patients were found to have IBS-related visits during a median follow-up of 12 years, a number more consistent with these findings (Ann Intern Med 1995;122:107–112.) Reasons that may account for differences in prevalence of IBS persistence between the WHS study and the studies included in El Serag et al's systematic review is that the latter included both retrospective and prospective studies, diagnostic criteria varied, and the prevalence of women ranged from 36% to 100%. An additional finding in the WHS was that there was no greater likelihood of developing de novo IBS at 8 years in cases exposed to acute bacterial gastroenteritis versus controls. Some limitations of the study are worth mentioning. First, even though the authors excluded enrollees beyond 2002/2003, recall bias of symptoms even at 2 years can cause misclassification of both cases and controls. Patients exposed to a severe cause of acute gastroenteritis, for instance, may be less apt to remember any prior milder IBS symptoms before the outbreak. Furthermore, Parry et al demonstrated that IBS is more frequently seen before diagnosis in patients with acute bacterial gastroenteritis (Am J Gastroenterol 2003;98:327–331), making exclusion of IBS especially important. The WHS also did not report in this study about other functional somatic syndromes such as fibromyalgia, chronic fatigue syndrome, and interstitial cystitis, which frequently coexist with IBS. It is conceivable that participants did not have preinfection IBS but had another functional syndrome that could have predisposed them to developing IBS. Second, in evaluating differences between participants and terminates in Table 2, the authors characterized all patients from the WHS cohort including those excluded by the study criteria. The addition of these patients to this table make it difficult to truly assess for differences between participants included in the study and terminates from the study, a potential concern if it is believed that those with more severe illness are disproportionately more likely to seek health care (thereby increasing the prevalence of PI-IBS). The terminates in 2008 had some features that are associated with greater risk for PI-IBS (fever, weight loss, more with a longer duration of diarrhea) but other features that are not (fewer women, lower stool frequency). Third, it is unclear if there was a misdiagnosis of PI-IBS or if these patients had developed other diseases at the time of follow-up because health records were not reviewed throughout the duration of the study. For instance, a small increased risk of inflammatory bowel disease has been reported after acute infectious gastroenteritis (1.2% in cases vs 0.5% in controls; Gastroenterology 2009;137:415–418). Fourth, no assessment of the severity of PI-IBS at various time points was performed. It would have been interesting to determine whether certain clinical factors predict a more severe disease course in PI-IBS. Recent studies have identified clinical features that predict IBS severity in a non–PI-IBS population (Am J Gastroenterol 2008;103:2536–2543) and that specific features of pain drive IBS illness severity more than other features including intensity, constancy, frequency, and predictability of pain (Aliment Pharmacol Ther 2010;32:1192–1202). Lastly, patients were diagnosed by Rome I criteria as opposed to Rome II criteria, which are more restrictive and have been shown to produce lower estimates of prevalence (Am J Gastroenterol 2000;95:3176–183). In a meta-analysis, the incidence of PI-IBS ranged from 3% to 14% in studies that used Rome II criteria versus 16% to 32% in studies that used Rome I criteria (Aliment Pharmacol Ther 2007;26:535–544). Recently, the WHS investigators have also identified several genes that encode proteins involved in epithelial cell barrier function and the innate immune response to enteric bacteria that are associated with development of PI-IBS (Gastroenterology 2010;138:1502–1513). This finding suggests that certain individuals may be more predisposed to developing PI-IBS when exposed to a gastroenteritis. However, alterations in gene expression need to be confirmed with microarray analysis because gene expression can be altered by environmental influences (eg, chronic stress which is a predictor of PI-IBS (Gut 1999;44:400-6). Future studies should evaluate whether Toll-like receptor-9, interleukin-6, and CDH1 genetic variants are also associated with non–PI-IBS. The WHS cohort continues to provide invaluable data regarding the long-term prognosis of PI-IBS. As these patients are followed over the course of their lives, it will be interesting to see how and if their symptoms continue to evolve. Will they be more likely to develop inflammatory bowel disease or other gastrointestinal or nongastrointestinal illnesses? Will they continue to demonstrate subtype phenotypic instability? Will their symptoms be comparable in severity with those with de novo IBS? Finally, do PI-IBS patients respond to different therapies (eg, anti-inflammatory agents) compared with non–PI-IBS patients? The WHS Investigators have followed a truly unique cohort of patients unmatched in their size, their duration of follow-up, and their availability of DNA samples. From a national tragedy affecting thousands and resulting in 6 deaths, the WHS Investigators have published a detailed, 8-year follow-up of survivors of this cohort, contributing immensely to our knowledge of the natural history of PI-IBS. ReplyGastroenterologyVol. 140Issue 2PreviewWe are grateful to Drs Wang and Chang for their thoughtful review of our study of the 8-year prognosis of postinfectious irritable bowel syndrome (IBS) in the Walkerton Health Study cohort. The outbreak of acute gastroenteritis in this community in 2000 was a public health tragedy, but has provided valuable insight into the natural history and long-term health consequences of acute gastroenteritis. Full-Text PDF

Abstract:Irritable bowel syndrome (IBS) is a common gastrointestinal disorder characterized by recurrent abdominal pain or discomfort associated with altered bowel movements. It affects 8%-22% of the population in Western countries and the prevalence of IBS prevalence is 5%-10% in most Asian communities.1-4 Although IBS is not a life-threatening disease, IBS patients often suffer significantly from the syndrome and have an impaired quality of life because of the chronic nature of the disease and its recurrence rate. IBS also has a significant socioeconomic impact. The pathophysiology underlying IBS remains elusive, however, more and more studies have emerged and the mechanism is expected to be disclosed soon. Nevertheless, IBS is a chronic disease caused by multiple factors, such as psychological factors, heredity, and infections, which have contributed to the uncertainty in establishing an appropriate animal model, detection of hypersensitivity, as well as clinical practice. This article discusses the controversies and limitations which exist in IBS studies, and hope that in so doing, IBS studies will become more standardized. Animal studies Animal models Currently, IBS animal models are classified into several types according to the underlying pathogenesis, as follows:5 psychological, inflammatory, neurocrine, secondary to colorectal distention, and secondary to early adverse life events. There is no question that these models provide approaches to explore the pathogenesis and provide improved therapy. However, the same animal model may result in different outcomes because of the lack of a uniform approach to experimental manipulation in IBS studies. For example, partial restraint stress is a widely used animal model of IBS caused by psychological factors. The experimental process is straightforward and involves wrapping the animal's fore shoulders, upper forelimbs, and thoracic trunk in a confining harness of paper tape to restrict movement. But, how many layers should the paper harness be? How much pressure should be exerted by the wrap? Does the animal need to be anaesthetized before restraining? Since there are no uniform standards, these small differences may significantly influence the establishment of a legitimate and valid model. Detective methods used in animal models Visceral hypersensitivity to noxious, as well as physiologic stimuli, is considered to be a clinical hallmark of IBS.6 Hence, many researchers use the alteration of visceral hypersensitivity as an index to validate a potential model or the effect of intervention and treatment. Usually, colorectal hypersensitivity in animals is expressed by the visceral motor reflex, which is detected by electromyography (EMG) or observed by the abdominal withdrawal reflex (AWR). Another index for hypersensitivity is the cardio reflex, i.e., detection of a change in the carotid artery pressure when the animal is anaesthetized. Since IBS is thought to be correlated with stress, psychology, and the environment, there is a legitimate concern that study methodology may have an influence on the experimental animals. About the EMG As an objective index for the detection of visceral hypersensitivity, EMG is used widely in IBS animal models.7-9 The method of the surgical procedure is as follows: 1) after the animal is anesthetized, the electrodes (Teflon-coated stainless steel wire) are sewn into the external oblique abdominal musculature for EMG recording; 2) the EMG electrodes are then subcutaneously guided to the dorsum of the neck and externalized for future access; 3) after resting for 5-7 days, the animals undergo an EMG. However, the potential influence of the complex surgery on functional IBS in animals is concerning. It has been reported that the subcutaneous implantation of a cotton thread (1 cm in length and 7 mg in weight) induces rapid formation of granulation tissue.10 It was found that the implantation of a cotton thread increased histidine decarboxylase activity in the tissue surrounding the implanted cotton thread, including the skin, the cutaneous muscle layer, the subcutaneous tissues, and the granulation tissue from 1 to 5 days after implantation. Histamine was produced rapidly in the growing granulation tissue,11,12 which was thought to be involved in central nervous system hypersensitivity. We know that the electrode is much larger than the cotton thread, and we presume that the granulation tissue elicited by the electrode is also much greater than that elicited by the cotton thread. The effect of implanting an electrode on the animal is unknown. Influence of limited devices In order to prevent damage to the balloon, the animals are usually placed in limited devices, such as Bollman restrainers for mice and plastic tunnels (6 cm in diameter and 25 cm length) for rats,13,14 in which the animals can not move, escape, or turn around. The animals are typically acclimated to this procedure 3-10 days before colorectal distension to minimize stress reactions during the experiments. Colorectal distension is then performed with different pressures. The process is conducted by a 10-second distension followed by a 5-minute resting period. Each level of distension (10, 30, 40, and 60 mmHg) is repeated 3 times. It takes more than 1 hour to complete the colorectal distension in one animal. We have learned that acute partial restraint stress can significantly enhance the abdominal response to rectal distension as compared with sham partial restraint stress for distension. Moreover, chronic partial restraint stress can also induce a hyperalgesic response at the highest pressure. Both acute and chronic partial restraint stress can increase substance P-induced histamine release in vitro.14 The animals usually exhibit increased defecation rates when in the limited devices. Even though all the experimental animals are under the same experimental conditions, such as the limited devices, we are curious about what effect the limited device will have over functional intestinal disease? Score of the AWR The AWR is an involuntary motor reflex similar to the visceromotor reflex, but has the advantage that it requires no additional surgery to implant recording electrodes and wires in the abdominal muscles. However, the AWR requires observation of contractions in the abdominal wall musculature and this semi-quantitative score is subjective, despite the double-blind methods used in most studies. Clinical studies Questions also exit in clinical studies and practice. It is well known that IBS is diagnosed by the identification of typical symptoms, a normal physical examination, and the exclusion of alarming features. Though the development and refinement of symptom-based criteria of IBS has greatly facilitated the diagnosis of this condition, some physicians lack knowledge about IBS. Charapata et al15 studied 166 physicians and found that the attending physician's knowledge of the Rome criteria was less than 30% among non-gastroenterologists. Only 7% could select the correct positive predictive value of the Rome criteria for IBS and only 20 of 76 attending physicians had used the Rome criteria in practice. Although the study has some limitations, it does illustrate the problems which exist in clinical practice with respect to IBS. Similarly, a study in Taiwan16 showed that more than 90% of registered nurses in tertiary care facilities had very limited knowledge about IBS, while almost one-half of them could not explain IBS clearly to their patients. Agreus17 also found the knowledge of IBS criteria was poor among 136 general practitioners. He suggested that the Rome definition and the Manning criteria were too complicated for use in the busy clinical workday. Moreover, many of the patients presented with poly-symptoms, which made the diagnosis of IBS difficult and many physicians drew their diagnosis based on their clinical impression, rather than applying definitions developed for the purposes of research.18 It is also difficult for the patients to accurately recall details regarding defecation and abdominal pain during the past 6 months. However, animal and clinical studies should still continue, despite the unanswered questions, controversies, and limitations! In our opinion, the following approach may prove useful. Standardize the animal model A specialized team is needed to verify the animal model, standardize the performance details, and monitor the process. Then, the details and standards, as well as the quality-control objectives of the experiment, are released to a magazine or on a public website so that many can use the uniform animal model for further studies. This may provide a comparison in different studies with the same models, which will benefit the evidence-based studies, and also have an important role in making plentiful use of experimental resources worldwide. Make the method more objective and scientific Regarding the question of the invasive detection of visceral hypersensitivity in the subjective assessment of the AWR score, with the development of modern techniques, the collection of images is easy. Wang et al19 used a digital video film to record the facial motor musculature, such as wrinkling the forehead, closing the eyes, and wiggling the nose, and entered the data into a computer so as to analyze the movement of the related muscles with Orisis software. Videomimicography could also be used as an objective approach to evaluate the distance between the lifted animal abdomen and the surface of the platform. It seems that no technical difficulties in data collection occurred; however, the key is to define a standard line and angle when recording. In order to avoid the potential stress of the restraint device, Welting et al20 developed a model using implanted radio telemetry for remote measurement of the visceromotor response to colorectal distension and showed that radio telemetry was a reliable and well-tolerated new tool for evaluating visceral sensitivity in rats. Popularize and modernize the clinical practice More and more cultural patterns have changed with the development of the web and clinical studies of IBS are not an exception. Bushnell et al21 transformed many IBS-related questionnaires into electronic data capture versions. They found that electronic data capture was easy and comparable to paper questionnaires in internal consistency and test-retest reliability, and had greater patient acceptability. Enck et al22 also placed a symptom scale for gastrointestinal symptoms on a genuine website and linked it to the website of the German IBS Patient Group, then asked the patients to report gastrointestinal symptoms. The patients who had finished the questionnaire would immediately receive an assessment of their health-related quality of life by a series of validated scales. The open internet questionnaire made the symptoms and quality of life assessment feasible and comparable to those from other sources of assessments. The internet makes it easy for physicians to diagnose IBS and assess the quality of life of their patients. We hope that a worldwide IBS patient group will be established with the internet for the use of physicians managing patients with IBS throughout the world. The latest information will be released on the internet, and it will be translated into other languages so that people can make full use of the resources and assure that IBS patients receive the best information. We hope that in the near future IBS studies and practice will become much easier and more validated with greater quality control and with the modern internet technology.

The Walkerton outbreak revisited at year 8: predictors, prevalence, and prognosis of postinfectious irritable bowel syndrome.

Controversies and Limitations in Irritable Bowel Syndrome Studies

PWE-131 Fodmap Intake and the Risk of Irritable Bowel Syndrome in the Community: a Prospective Study

Tu2066 Prevalence of Irritable Bowel Syndrome in China: Joint Effects of Psychiatric Morbidity with Life Event Stress and Lactose Intake

Prevalence and predictors of small intestinal bacterial overgrowth in irritable bowel syndrome: a systematic review and meta-analysis

Post-infectious IBS: Defining its clinical features and prognosis using an internet-based survey

Risk factors of developing post-infectious irritable bowel syndrome in shigellosis patients, five years after the hospitalization during the outbreak

Small Intestinal Bacterial Overgrowth in Patients with Irritable Bowel Syndrome: Clinical Characteristics, Psychological Factors, and Peripheral Cytokines

Irritable Bowel Syndrome and Long-Term Risk of Cancer: A Prospective Cohort Study Among 0.5 Million Adults in UK Biobank

Early Infections and the Risk of Irritable Bowel Syndrome: A Case-Control Study

Health sequelae of human cryptosporidiosis-a 12-month prospective follow-up study

'Holiday sickness'-reported exploratory outcome of over 500 United Kingdom holidaymakers with travellers' diarrhoea

P1147 Symptoms of irritable bowel syndrome are common in patients in remission from Inflammatory Bowel Disease: Results from an observational population-based cohort study in Norway

Study on clinical significance of different subgroups of irritable bowel syndrome patients in Zhejiang province

Intestinal Microecology and Quality of Life in Irritable Bowel Syndrome Patients

Association Between Allergic Diseases And Irritable Bowel Syndrome: A Retrospective Study

Changes in the symptom pattern and the densities of large-intestinal endocrine cells following Campylobacter infection in irritable bowel syndrome: a case report

The epidemiology of irritable bowel syndrome

Transcriptomic and Metabolomic Correlates of Increased Colonic Permeability in Postinfection Irritable Bowel Syndrome

Comorbidities, biomarkers and cause specific mortality in patients with irritable bowel syndrome: A phenome-wide association study

Ultra-Processed Food Consumption and Long-Term Risk of Irritable Bowel Syndrome: A Large-Scale Prospective Cohort Study